Novartis exercises Alcon option

Novartis AG (NYSE:NVS; SIX:NOVN) exercised its option to acquire 52% of Alcon Inc. (NYSE:ACL) from Nestle

Read the full 160 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE